Generic drug prescription: Possible issues, impacts and consequences
Abstract
The generic drug and branded drug is a confusing concept, and is a matter of serious concern for the pharmaceutical sector after the imposition of the rule that every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drugs. The generic drug should be bioequivalent before they can be prescribed as an alternative from their branded counterparts.
References
2. What Are Generic Drugs? http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSa... ucm144456.htm. (Accessed on 27-april-17).
3. US-FDA: Guidance for Industry - Bioavailability and Bioequivalence. In FDA Guidance for Industry.
4. Process for Approving Generic Drugs. http://www.fda.gov/Training/ ForHealthProfessionals/ucm090215.htm. (Accessed on 27-April-17)
5. Guidelines for bioavailability and bioequivalence studies, central drug standard organization, directorate general of health services, ministry of health and family welfare, government of india, new delhi, (2005), page 3.

